Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443280) titled 'Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiotic' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Tungs' Taichung Metroharbour Hospital
Condition:
Symbiotic
Uremic Toxins
Gut -Microbiota
Intervention:
Dietary Supplement: Multispecies Synbiotic Supplementation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 1, 2026
Target Sample Size: 30
Countries of Recruitment:
Taiwan
To know more, visit...